Euro vs US Dollar

Registrieren Sie sich kostenlos, um Echtzeitkurse, interaktive Charts, Live-Optionsfluss und mehr zu erhalten.

Registrieren

AKBA Akebia Therapeutics Inc

1,75

-0,04 (-2,23%)

11 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Akebia Therapeutics Charts.

Akebia Therapeutics (NASDAQ:AKBA)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Akebia Therapeutics Charts.

News Akebia Therapeutics Inc

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Donnerstag 2 Januar 2025 (1 Woche vor) • PR Newswire (US)

Akebia Therapeutics to Present at the 43rd Annual J.P. Morgan Healthcare Conference
Mittwoch 18 Dezember 2024 (3 Wochen vor) • PR Newswire (US)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Dienstag 3 Dezember 2024 (1 Monat vor) • PR Newswire (US)

U.S. Renal Care Enrolled First Patients in the VOICE Collaborative Clinical Trial of Vafseo® (vadadustat) for CKD Patients on Dialysis
Dienstag 3 Dezember 2024 (1 Monat vor) • PR Newswire (US)

Akebia Therapeutics to Present at the 36th Annual Piper Sandler Healthcare Conference
Montag 25 November 2024 (2 Monate vor) • PR Newswire (US)

Vadadustat Alternative Dosing Study Results Published in the American Journal of Kidney Disease
Donnerstag 14 November 2024 (2 Monate vor) • PR Newswire (US)

Akebia Therapeutics to Present at the Jefferies London Healthcare Conference
Dienstag 12 November 2024 (2 Monate vor) • PR Newswire (US)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Freitag 8 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Donnerstag 7 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Akebia Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights
Donnerstag 7 November 2024 (2 Monate vor) • PR Newswire (US)

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Freitag 1 November 2024 (2 Monate vor) • PR Newswire (US)

Weitere Akebia Therapeutics Inc News-Artikel

Health Care Select Sector

Financial Select Sector

Energy Select Sector SPDR

Deutsche Telekom (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen